Apollomics, Inc. (APLM)
NASDAQ: APLM · IEX Real-Time Price · USD
0.194
-0.003 (-1.73%)
At close: Jul 2, 2024, 3:55 PM
0.200
+0.006 (3.31%)
After-hours: Jul 2, 2024, 7:52 PM EDT
Apollomics Market Cap
Apollomics has a market cap or net worth of $21.09 million as of July 2, 2024. Its market cap has decreased by -95.17% in one year.
Market Cap
21.09M
Enterprise Value
-12.07M
1-Year Change
-95.17%
Ranking
Category
Stock Price
$0.19
Market Cap Chart
Since October 8, 2021, Apollomics's market cap has decreased from $118.20M to $21.09M, a decrease of -82.16%. That is a compound annual growth rate of -46.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 17.20M | -80.07% |
| Dec 29, 2023 | 86.30M | -37.96% |
| Dec 30, 2022 | 139.10M | 4.35% |
| Dec 31, 2021 | 133.30M | 12.77% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cocrystal Pharma | 23.70M |
| Biora Therapeutics | 23.68M |
| SeaStar Medical Holding | 23.60M |
| BiomX | 23.46M |
| OneMedNet | 23.43M |
| Gain Therapeutics | 23.11M |
| Aptorum Group | 22.70M |
| Unity Biotechnology | 22.67M |